If you have prescription coverage through Medicare Part D and you want to use Meds by Mail instead, you can cancel your Part D coverage
The primary endpoint in DEVOTE was time from randomization to the first occurrence of a 3-component major adverse cardiovascular event (MACE): cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke
In the future, we will develop small molecule inhibitors or activators for specific transporters such as SLC25A39 and xCT, and use gene editing tools (such as CRISPR/Cas9) to precisely edit related genes to achieve precise regulation of GSH metabolism, providing more targeted means for disease treatment
The global demand for glucagon-like peptide-1 (GLP-1) receptor agonists has surged due to their effectiveness in lowering blood glucose levels, promoting weight loss, and providing cardiovascular benefits [1,2]
Ghadjar P, Kaanders JH, Poortmans P, et al